Non-Hormonal Treatments for Vasomotor Symptoms
In this interview, News Medical speaks with Dr Katie Barber, Clinical Director, GP, and Registered BMS Menopause Specialist at…
Popular GLP-1 drugs significantly reduce major cardiovascular events,
Widely used diabetes and obesity drugs show powerful heart-protective effects in high-risk patients, offering new momentum for their…
Veradermics Posts Positive Top-Line Phase II/III Results for Oral Minoxidil Pill
Key Points Veradermics reported positive Part A results for VDPHL01, meeting both co‑primary endpoints with significant hair‑count gains…
Triple combination pill reduces recurrent stroke risk
Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of…
Alzheimer’s monoclonal antibodies fail to deliver meaningful results
Despite successfully removing amyloid plaques from the brain, widely anticipated antibody therapies fail to deliver meaningful cognitive improvements,…
Exercise and ibuprofen help reduce cognitive impairment during chemotherapy
Up to 80% of people who receive chemotherapy experience cancer-related cognitive impairment, which most commonly involves mild-to-moderate changes such…
Two new TB vaccines show safety but limited protection
Two new vaccines to prevent tuberculosis (TB) are safe for use in adults and children, but they do…
Study reveals how a promising bacterial therapy reduces recurrent bacterial vaginosis
A new study from the Kwon Lab at the Ragon Institute, published in Cell Host & Microbe, provides the most detailed…
Oral semaglutide fails to slow early Alzheimer’s decline in two phase 3 trials
Despite hopes raised by earlier observational studies and biomarker shifts, The Lancet trials found that oral semaglutide did…
Romiplostim prevents chemotherapy-induced thrombocytopenia in phase 3 trial
Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the…
Low‑dose oral lithium may help slow the decline of verbal memory, trial suggests
Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization. An exploratory clinical trial from…
Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…